Testing the Addition of Copanlisib to Eribulin in Metastatic Triple Negative Breast Cancer

Clinical trial NCT04345913 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT04345913
Sponsor: National Cancer Institute (NCI)
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Anatomic Stage III Breast Cancer AJCC v8 Anatomic Stage IV Breast Cancer AJCC v8 Metastatic Triple-Negative Breast Carcinoma Unresectable Triple-Negative Breast Carcinoma

Start date: 2021-03-01
Primary completion: 2024-03-28
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.